pegylated L-asparaginase (Polaris Pharmaceuticals)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namepegylated L-asparaginase (Polaris Pharmaceuticals)
Drug Alias NameASNase-PEG
ClassificationBiologics > Protein drugs > Enzyme
Mechanisms of ActionAsparaginase stimulants
TargetsAsparaginase
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPolaris Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPolaris Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A